Of these, SRC was the most highly associated and was shown to bind to PTK2B/PYK2 to provide energy for anti-osteoporosis drugs and to prevent the inhibitory effect of calcitonin by activating mitochondrial cytochrome C oxidase [48]. The gene discussed is SRC; the disease is osteoporosis.